Introduction: The development of CRISPR technology has ushered in a new era in molecular diagnostics whereby genetic material can be very accurately and efficiently detected. Therefore, the incorporation of these technologies into diagnostic protocols represents a paradigm shift in precision medicine. This review aims to thoroughly assess the advancements and application of CRISPR into next-generation diagnostic tools, focusing on both existing and emerging technologies. Methods: The review presents CRISPR-based systems as historically moving from simple genome-editing tools into advanced diagnostic platforms, with emphasis on utilities that enhance diagnostic capability such as field-deployable assays and multiplex detection methodologies. Results: The review discusses CRISPRs-Cas13 and Cas12-and-Cas9 systems and their applications in the detection of infectious diseases, genetic disorders, and cancer. Emerging Techniques: The article points out emerging techniques using CRISPR for real-time monitoring and point-of-care diagnostics, showcasing the technology’s transformational capacity in diagnostic practice across various fields. Challenges and opportunities: The review outlines challenges and opportunities for CRISPR diagnostics, which include artificial intelligence configuration, multiplexing capability, and possibilities for personalized medicine. Conclusion: This review aims at highlighting the disrupting powers of CRISPR technologies on diagnostic systems toward the development of accurate, accessible, and inexpensive solutions for diagnostics in precision health.
No takes yet. Share an insight, caveat, or question.
Sneha et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: